Medtech company appoints new chief financial officer
Daniel Seibert has been appointed as Chief Financial Officer (CFO) to the executive board of Raumedic, Helmbrechts. The appointment became effective as of 1st April 2019.
Seibert succeeds Bernhard Kernen, who left the medical technology company in March this year.
Seibert is a business administration graduate with experience within the biotechnology and medical technology sectors. Additionally, he has fourteen years of experience as CFO within medium-sized enterprises.
Seibert's new role will include working within the accounting, controlling, purchasing, IT, customer service and requirements planning, and legal departments.
“Medical technology is very exciting. It offers a sphere of work that is very meaningful in the truest sense of the word, since its clear mission is to enhance healthcare and quality of life,” states Seibert. “I also see great growth potential for the company and would like to do my bit in helping it tap that.”
Stefan Seuferling, the company’s chairman of the executive board said, “we warmly welcome Mr. Seibert to the executive board and wish him every success in his new environment. His in-depth know-how will help us control important processes, and so the further development of Raumedic, even better.”